Observational study of a motion capture device (AKIRA) in patients with ALS

A non-interventional, prospective, observational study of a motion capture device (AKIRA) in patients with amyotrophic lateral sclerosis (ALS)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1030230648

Enrollment

Registered

2024-02-22

Start date

2021-01-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic Lateral Sclerosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients will be diagnosed with Definite ALS, Probable ALS, or Probable laboratory-supported ALS according to the El Escorial revised criteria for the diagnosis of ALS 2. Patients will be >= 20 years of age at the time the ICF is signed 3. Patients who can walk independently at a specified distance for video shooting 4. Patients who regularly visit the Yoshino Clinic about once a month 5. Patients who provided a signed and dated informed consent form (ICF) to participate in the study

Exclusion criteria

Exclusion criteria: 1. Patients who have the presence of any clinically significant disease 2. Patients who are not eligible to participate in the study, as judged by the Investigator

Design outcomes

Primary

Measure	Time frame
- Motion data using AKIRA	—

Secondary

Measure	Time frame
- ALSFRS-R score - % Forced vital capacity (%FVC) - expiratory gas analysis - Laboratory Tests (creatine kinase, creatinine, uric acid) - InBody (body composition)	—

Contacts

Public ContactInformation Desk Clinical Research

Tanabe Pharma

cti-inq-ml.JP@ml.tanabe-pharma.com+81-120-753-280

Outcome results